According to a recent LinkedIn post from Flatiron Health, TailorMed has joined the Flatiron Vendor Network to support oncology practices in connecting patients with financial assistance and adherence resources. The post indicates that this integration is aimed at improving support throughout the medication journey for patients using therapies managed via Flatiron’s platforms.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post highlights that TailorMed’s tools will be available across the OncoEMR network, potentially enhancing providers’ ability to navigate patients’ financial barriers to care. For investors, this suggests continued expansion of Flatiron’s ecosystem around its core oncology EHR, which could strengthen customer stickiness and increase the value proposition for practices.
The collaboration may position Flatiron more competitively in value-based and patient-centric oncology care, where financial toxicity is an increasing concern. Over time, broader adoption of integrated financial navigation solutions could support higher utilization of OncoEMR and related services, with potential positive implications for recurring revenue and long-term partnership opportunities with providers and life science stakeholders.